𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast

✍ Scribed by Jones, Mary; Redford, Judith; Wagstaff, J.; Sellwood, R.A.; Howell, A.; Mackintosh, J.

Book ID
122900238
Publisher
Elsevier Science
Year
1988
Weight
579 KB
Volume
24
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vascular endothelial growth factor is as
Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma
✍ Peggy Manders; Louk V. A. M. Beex; Vivianne C. G. Tjan-Heijnen; Paul N. Span; C. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## BACKGROUND Vascular endothelial growth factor (VEGF) is a mediator of angiogenesis and is associated with a poor prognosis in patients with primary breast carcinoma. In the current study, the authors investigated whether there was an association between VEGF levels in tumor tissues

Vascular endothelial growth factor is as
Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma
✍ Kadri Altundag; Emin Tamer Elkiran; Ozden Altundag 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 2 views

## Eighteen-Year Results in the Treatment of Early Breast Carcinoma with Mastectomy Versus Breast Conservation Therapy W e applaud the recent report by Poggi et al. 1 regarding the 18-year follow-up data of the National Cancer Institute randomized trial on breast conservation therapy (BCT) versus